Research ArticleAccepted Article
Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus
Wietske M. Lambers, Johanna Westra, Hendrika Bootsma and Karina de Leeuw
The Journal of Rheumatology November 2020, jrheum.200726; DOI: https://doi.org/10.3899/jrheum.200726
Wietske M. Lambers
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl
Johanna Westra
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl
Hendrika Bootsma
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl
Karina de Leeuw
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus
Wietske M. Lambers, Johanna Westra, Hendrika Bootsma, Karina de Leeuw
The Journal of Rheumatology Nov 2020, jrheum.200726; DOI: 10.3899/jrheum.200726
Accepted manuscript
Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus
Wietske M. Lambers, Johanna Westra, Hendrika Bootsma, Karina de Leeuw
The Journal of Rheumatology Nov 2020, jrheum.200726; DOI: 10.3899/jrheum.200726